Literature DB >> 34741306

TAB2 variants cause cardiovascular heart disease, connective tissue disorder, and developmental delay.

Jennifer Hanson1, Daniel Brezavar1, Susan Hughes2, Shivarajan Amudhavalli2, Emily Fleming2, Dihong Zhou2, Joseph T Alaimo3,4, Penelope E Bonnen1.   

Abstract

Congenital heart defects (CHD) are the most commonly occurring birth defect and can occur in isolation or with additional clinical features comprising a genetic syndrome. Autosomal dominant variants in TAB2 are recognized by the American Heart Association as causing nonsyndromic CHD, however, emerging data point to additional, extra-cardiac features associated with TAB2 variants. We identified 15 newly reported individuals with pathogenic TAB2 variants and reviewed an additional 24 subjects with TAB2 variants in the literature. Analysis showed 64% (25/39) of individuals with disease resulting from TAB2 single nucleotide variants (SNV) had syndromic CHD or adult-onset cardiomyopathy with one or more extra-cardiac features. The most commonly co-occurring features with CHD or cardiomyopathy were facial dysmorphism, skeletal and connective tissue defects and most subjects with TAB2 variants present as a connective tissue disorder. Notably, 53% (8/15) of our cohort displayed developmental delay and we suspect this may be a previously unappreciated feature of TAB2 disease. We describe the largest cohort of subjects with TAB2 SNV and show that in addition to heart disease, features across multiple systems are present in most TAB2 cases. In light of our findings, we recommend that TAB2 be included on the list of genes that cause syndromic CHD, adult-onset cardiomyopathy, and connective tissue disorder.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  clinical genetics; neurodevelopmental disorders; pediatric cardiology; rare disease

Mesh:

Substances:

Year:  2021        PMID: 34741306      PMCID: PMC8745489          DOI: 10.1111/cge.14085

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  22 in total

1.  TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.

Authors:  G Takaesu; S Kishida; A Hiyama; K Yamaguchi; H Shibuya; K Irie; J Ninomiya-Tsuji; K Matsumoto
Journal:  Mol Cell       Date:  2000-04       Impact factor: 17.970

2.  Autosomal dominant frontometaphyseal dysplasia: Delineation of the clinical phenotype.

Authors:  Emma M Wade; Zandra A Jenkins; Philip B Daniel; Tim Morgan; Marie C Addor; Lesley C Adés; Debora Bertola; Axel Bohring; Erin Carter; Tae-Joon Cho; Christa M de Geus; Hans-Christoph Duba; Elaine Fletcher; Kinga Hadzsiev; Raoul C M Hennekam; Chong A Kim; Deborah Krakow; Eva Morava; Teresa Neuhann; David Sillence; Andrea Superti-Furga; Hermine E Veenstra-Knol; Dagmar Wieczorek; Louise C Wilson; David M Markie; Stephen P Robertson
Journal:  Am J Med Genet A       Date:  2017-05-12       Impact factor: 2.802

3.  TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling.

Authors:  Hideki Sanjo; Kiyoshi Takeda; Tohru Tsujimura; Jun Ninomiya-Tsuji; Kunihiro Matsumoto; Shizuo Akira
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

4.  Heterozygous Mutations in MAP3K7, Encoding TGF-β-Activated Kinase 1, Cause Cardiospondylocarpofacial Syndrome.

Authors:  Carine Le Goff; Curtis Rogers; Wilfried Le Goff; Graziella Pinto; Damien Bonnet; Maya Chrabieh; Olivier Alibeu; Patrick Nistchke; Arnold Munnich; Capucine Picard; Valérie Cormier-Daire
Journal:  Am J Hum Genet       Date:  2016-07-14       Impact factor: 11.025

5.  Mutations in MAP3K7 that Alter the Activity of the TAK1 Signaling Complex Cause Frontometaphyseal Dysplasia.

Authors:  Emma M Wade; Philip B Daniel; Zandra A Jenkins; Aideen McInerney-Leo; Paul Leo; Tim Morgan; Marie Claude Addor; Lesley C Adès; Debora Bertola; Axel Bohring; Erin Carter; Tae-Joon Cho; Hans-Christoph Duba; Elaine Fletcher; Chong A Kim; Deborah Krakow; Eva Morava; Teresa Neuhann; Andrea Superti-Furga; Irma Veenstra-Knol; Dagmar Wieczorek; Louise C Wilson; Raoul C M Hennekam; Andrew J Sutherland-Smith; Tim M Strom; Andrew O M Wilkie; Matthew A Brown; Emma L Duncan; David M Markie; Stephen P Robertson
Journal:  Am J Hum Genet       Date:  2016-07-15       Impact factor: 11.025

6.  Clinical whole-exome sequencing for the diagnosis of mendelian disorders.

Authors:  Yaping Yang; Donna M Muzny; Jeffrey G Reid; Matthew N Bainbridge; Alecia Willis; Patricia A Ward; Alicia Braxton; Joke Beuten; Fan Xia; Zhiyv Niu; Matthew Hardison; Richard Person; Mir Reza Bekheirnia; Magalie S Leduc; Amelia Kirby; Peter Pham; Jennifer Scull; Min Wang; Yan Ding; Sharon E Plon; James R Lupski; Arthur L Beaudet; Richard A Gibbs; Christine M Eng
Journal:  N Engl J Med       Date:  2013-10-02       Impact factor: 91.245

7.  Genetic Basis of Severe Childhood-Onset Cardiomyopathies.

Authors:  Catalina Vasilescu; Tiina H Ojala; Virginia Brilhante; Simo Ojanen; Helena M Hinterding; Eino Palin; Tero-Pekka Alastalo; Juha Koskenvuo; Anita Hiippala; Eero Jokinen; Timo Jahnukainen; Jouko Lohi; Jaana Pihkala; Tiina A Tyni; Christopher J Carroll; Anu Suomalainen
Journal:  J Am Coll Cardiol       Date:  2018-11-06       Impact factor: 24.094

8.  Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.

Authors:  Jack A Kosmicki; Kaitlin E Samocha; Daniel P Howrigan; Stephan J Sanders; Kamil Slowikowski; Monkol Lek; Konrad J Karczewski; David J Cutler; Bernie Devlin; Kathryn Roeder; Joseph D Buxbaum; Benjamin M Neale; Daniel G MacArthur; Dennis P Wall; Elise B Robinson; Mark J Daly
Journal:  Nat Genet       Date:  2017-02-13       Impact factor: 38.330

9.  Protein molecular modeling techniques investigating novel TAB2 variant R347X causing cardiomyopathy and congenital heart defects in multigenerational family.

Authors:  Thomas R Caulfield; John E Richter; Emily E Brown; Ahmed N Mohammad; Daniel P Judge; Paldeep S Atwal
Journal:  Mol Genet Genomic Med       Date:  2018-04-26       Impact factor: 2.183

10.  A novel TAB2 nonsense mutation (p.S149X) causing autosomal dominant congenital heart defects: a case report of a Chinese family.

Authors:  Jia Chen; Huizhen Yuan; Kang Xie; Xinrong Wang; Linglong Tan; Yongyi Zou; Yan Yang; Lu Pan; Junfang Xiao; Ge Chen; Yanqiu Liu
Journal:  BMC Cardiovasc Disord       Date:  2020-01-20       Impact factor: 2.298

View more
  1 in total

1.  The MAP3K7 gene: Further delineation of clinical characteristics and genotype/phenotype correlations.

Authors:  Geeske M van Woerden; Richelle Senden; Charlotte de Konink; Rossella A Trezza; Anwar Baban; Jennifer A Bassetti; Yolande van Bever; Lynne M Bird; Bregje W van Bon; Alice S Brooks; Qiaoning Guan; Eric W Klee; Carlo Marcelis; Joel M Rosado; Lisa A Schimmenti; Amy R Shikany; Paulien A Terhal; Kathryn Nicole Weaver; Marja W Wessels; Hester van Wieringen; Anna C Hurst; Catherine F Gooch; Katharina Steindl; Pascal Joset; Anita Rauch; Marco Tartaglia; Marcello Niceta; Ype Elgersma; Serwet Demirdas
Journal:  Hum Mutat       Date:  2022-07-29       Impact factor: 4.700

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.